Case Distillery
BLOG · ISSUE #003

$602 MRR in 60 Days: A Diabetic Meal Planner With a Hidden Data Moat

Jun 20, 2026·2 min read

A backend dev with no nutrition background shipped an AI meal planner for Type 2 diabetics on eight weekends. 86 paid users at $7/mo, $89/mo fixed cost, breakeven in week one. The diabetic-dad origin story is real. The moat is bigger than anyone in the Reddit thread caught.

The case at a glance: $602 MRR, 80 hours, one subreddit

Stack: Next.js, Supabase, OpenAI (GPT-4 + GPT-3.5), Stripe, Resend, Vercel. No beta. No customer interviews. He posted in r/diabetes on day one and let the market vote with cards.

What this AI meal planner is actually selling

The vertical is pre-medicalized. Type 2 diabetics over 50 don't need to be persuaded that food matters — they got the diagnosis. They're already paying $200/mo for glucose monitors. $7 doesn't register as a decision. Acquisition is "show up in the room they already live in." Diagnosis is the funnel.

The reframe is in the banner. Adding "All recommendations follow ADA 2025 guidelines" lifted conversion from 18% to 23% overnight. Not a line of product code changed. He changed the framing from AI-powered to doctor-approved. That single banner is worth roughly $110/mo of recurring revenue at current scale, growing linearly with users. In high-stakes verticals — medical, legal, financial — credibility framing always beats technology framing.

The signal in the offer

Build the boring version, then watch what users actually open. Eighty weekend hours, free tiers, no beta, no Indie Hackers feedback thread. Twelve paid users in seven days is the validation. Nothing else is.

The 4-hour feature carried the 76-hour product. "Flag the meals that spiked blood sugar" is the only thing testimonials mention. It's an if-else against a timestamp.

Distribution was one subreddit. A single r/diabetes post produced roughly a third of total paid revenue. Anyone writing a "best AI meal planner 2026" category page is solving the wrong problem.

The $7 price point is a self-inflicted wound in a vertical where users already accept that the disease costs money.

Want the full dissection?

This is the free preview. The full paid issue covers the four moves in the order they detonated, the pricing leash math, a 5-step replication playbook, and why cold launches don't work in 2026.

Read Issue #003 in full → First 100 subscribers lock $99/yr forever. After that it moves to the standard tier.